ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesR86.2

R86.2

Abnormal level of other drugs, medicaments and biological substances in specimens from male genital organs

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/11/2025

Code Description

ICD-10 R86.2 is a billable code used to indicate a diagnosis of abnormal level of other drugs, medicaments and biological substances in specimens from male genital organs.

Key Diagnostic Point:

R86.2 is used to classify abnormal levels of drugs, medicaments, and biological substances found in specimens taken from male genital organs. This may include abnormal concentrations of substances such as hormones, antibiotics, or other therapeutic agents that can affect male reproductive health. The presence of these substances can indicate various underlying conditions, including drug toxicity, hormonal imbalances, or exposure to environmental toxins. Symptoms may vary widely depending on the substance involved and the level of abnormality, ranging from reproductive dysfunction to systemic effects. Clinical evaluation often involves a thorough history, physical examination, and laboratory testing to identify the specific substances and their potential impact on health. Accurate coding requires careful documentation of the substances tested, their levels, and any associated symptoms or clinical findings.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of substances that can be involved
  • Need for precise laboratory results
  • Potential overlap with other codes
  • Documentation of clinical context

Audit Risk Factors

  • Inadequate documentation of substance levels
  • Failure to specify the type of drug or substance
  • Misinterpretation of lab results
  • Lack of correlation between symptoms and findings

Specialty Focus

Medical Specialties

Internal Medicine

Documentation Requirements

Detailed patient history, including medication use and exposure to substances.

Common Clinical Scenarios

Evaluation of male patients presenting with infertility or hormonal imbalances.

Billing Considerations

Consideration of polypharmacy and its effects on male reproductive health.

Emergency Medicine

Documentation Requirements

Acute care notes must include immediate lab results and clinical findings.

Common Clinical Scenarios

Patients presenting with acute symptoms related to drug toxicity or overdose.

Billing Considerations

Rapid assessment and documentation of substance levels are critical in emergency settings.

Coding Guidelines

Inclusion Criteria

Use R86.2 When
  • Follow the official ICD
  • CM coding guidelines, ensuring that the code is used only when there is clear documentation of abnormal levels of drugs or substances in male genital specimens

Exclusion Criteria

Do NOT use R86.2 When
No specific exclusions found.

Related CPT Codes

84146CPT Code

Testosterone, total

Clinical Scenario

Used when testing for testosterone levels in patients with suspected hormonal imbalances.

Documentation Requirements

Document the reason for testing and correlate with clinical findings.

Specialty Considerations

Endocrinologists may require additional documentation regarding treatment history.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of abnormal findings, improving the ability to track and analyze data related to drug levels in male genital specimens.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of abnormal findings, improving the ability to track and analyze data related to drug levels in male genital specimens.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of abnormal findings, improving the ability to track and analyze data related to drug levels in male genital specimens.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What types of substances are included under R86.2?

R86.2 includes a variety of drugs, medicaments, and biological substances that may be tested in specimens from male genital organs, such as hormones, antibiotics, and other therapeutic agents.